jVen Capital

jVen Capital is a venture capital and growth equity firm focused on life sciences investments in personalized medicine, digital health, genetics, and medical devices, based in Wilmington, Delaware, United States. The firm employs a hands-on approach, working closely with its portfolio companies to develop clear visions, implement rigorous business plans, and build successful enterprises within these specialized areas. jVen Capital has executed more than a dozen life sciences transactions, strategically deploying capital across its target sectors, which include innovative solutions in healthcare. Among its notable past investments is Foundation Medicine, a company in which jVen Capital participated in a pre-IPO Series B funding round prior to its acquisition in 2018. This active engagement underscores the firm's commitment to fostering growth and innovation within the broader life sciences ecosystem. jVen Capital was founded in 2007 by Evan Jones.